New Mechanisms in Glucose Control

Written by a world expert in the field, this pocketbook presents a clear overview of the new drugs and treatment therapies that have been developed in recent years to help perfect glycaemic control for the diabetic patient. The coverage surveys therapies both in development and approved by the FDA and European drug agency, including new NICE guidelines for the use of Victoza (liraglutide). It offers essential reading for all those in primary and secondary care involved in treating diabetic patients, notably hospital doctors, diabetes specialists, diabetes specialist nurses, and specialist trainees in diabetes/endocrinology. Anthony Barnett, Diabetes Centre, Birmingham Heartlands Hospital, Birmingham, UK - Jenny Grice, Medical Writer, France Table of Contents 1 Epidemiology and pathogenesis of type 2 diabetes. 2 Overview of current diabetes management. 3 The incretin system. 4 The incretin mimetics. 5 The dipeptidyl peptidase 4 inhibitors. 6 Sodium–glucose cotransporter–2 inhibitors. 7 Pipeline diabetes therapies. 8 Bariatric surgery for the treatment of type 2 diabetes. 9 Organisation of diabetes care. Index.